Exhibit 4.3


 


Execution Copy


 


BUSINESS DEVELOPMENT CORPORATION OF AMERICA



(a Maryland corporation)


 


$100,000,000


6.00% Senior Unsecured Notes due 2020

($1,000 Denominations)


 


PURCHASE AGREEMENT 


 


	Sandler O’Neill & Partners, L.P.	August 26, 2015


Keefe,
Bruyette & Woods, Inc.


UBS
Securities LLC


William Blair & Company,
L.L.C.

Ladenburg Thalmann & Co. Inc.


 


c/o


 


Sandler
O’Neill & Partners, L.P.


1251 Avenue of the Americas


Sixth Floor


New York, New York 10020


 


Keefe,
Bruyette & Woods, Inc.


787 Seventh Avenue


Fifth floor


New York, New York 10019


 


UBS Securities LLC 

1285 Avenue of the Americas

New York, New York 10019 


 


Ladies and Gentlemen:


 


Business Development
Corporation of America, a Maryland corporation (the “Company”) and BDCA Adviser, LLC, a Delaware limited liability
company (the “Adviser”), address you as the Initial Purchasers (as defined below). The Company proposes to sell to
Sandler O’Neill & Partners, L.P., Keefe, Bruyette & Woods, Inc. and UBS Securities LLC (the “Representatives”),
William Blair & Company, L.L.C. and Ladenburg Thalmann & Co. Inc. (together with the Representatives, the “Initial
Purchasers”) $100,000,000 aggregate principal amount of senior unsecured notes, due 2020 (the “Securities”).


 


The Securities will
be issued pursuant to the provisions of the Indenture of Trust (the “Indenture”), dated as of August 31, 2015, between
the Company and U.S. Bank National Association, a national banking association, as trustee (the “Trustee”).


 




     


     


    

 


The Company understands
that the Initial Purchasers propose to make an offering of the Securities on the terms and in the manner set forth herein and agrees
that the Initial Purchasers may resell, subject to the conditions set forth herein, all or a portion of the Securities to qualified
institutional buyers (“Subsequent Purchasers”) at any time after this Agreement has been executed and delivered. The
Securities are to be offered and sold through the Initial Purchasers without being registered under the Securities Act of 1933,
as amended, and the rules and regulations thereunder (the “1933 Act”), in reliance upon the exemption from such registration
afforded by Rule 144A of the 1933 Act (“Rule 144A”). Pursuant to the terms of the Securities and the Indenture,
investors (including the Initial Purchasers) that acquire Securities may only resell or otherwise transfer such Securities if such
Securities are hereafter registered for resale under the 1933 Act or if an exemption from the registration requirements of the
1933 Act is available (including the exemption afforded by Rule 144A).


 


In connection with
the sale of the Securities, the Company has prepared and delivered to the Initial Purchasers physical or electronic copies of a
preliminary offering memorandum dated August 25, 2015 (the “Preliminary Offering Memorandum”) and will prepare and
deliver to the Initial Purchasers, not later than the second business day following the date hereof, physical or electronic copies
of a final offering memorandum (the “Final Offering Memorandum”), each for use by the Initial Purchasers in connection
with their solicitation of purchases of, or offering of, the Securities. “Offering Memorandum” means, with respect
to any date or time referred to in this Agreement, the most recent offering memorandum (whether the Preliminary Offering Memorandum
or the Final Offering Memorandum, in each case including any amendment or supplement to either document), including exhibits thereto
and any documents incorporated therein by reference, which has been prepared and delivered by the Company to the Initial Purchasers
in connection with their solicitation of purchases of, or offering of, the Securities. “Disclosure Package” shall mean
the Preliminary Offering Memorandum together with the written information set forth in the Pricing Term Sheet attached hereto as
Exhibit A.


 


The Company has entered
into: (i) a Second Amended and Restated Investment Management Agreement with the Adviser, dated as of June 5, 2013 (the “Advisory
Agreement”); (ii) a Custody Agreement with U.S. Bank National Association, dated August 13, 2012, as amended (the “Custodian
Agreement”); (iii) an Amended and Restated Fund Administration Servicing Agreement with U.S. Bancorp Fund Services, LLC,
dated April 17, 2015 (the “Administration Agreement”); and (iv) an Amended and Restated Fund Accounting Agreement
with U.S. Bancorp Fund Services, LLC, dated April 17, 2015 (the “Accounting Agreement”). Collectively, the Advisory
Agreement, the Custodian Agreement, the Administration Agreement and the Accounting Agreement are herein referred to as the “Company
Agreements.” In addition, the Company has adopted a distribution reinvestment plan (the “Distribution Reinvestment
Plan”) pursuant to which the holders of Common Stock shall have their dividends automatically reinvested in additional Common
Stock of the Company unless they elect to receive such dividends in cash.


 


1.          Representations
and Warranties of the Company and the Adviser. The Company and the Adviser, jointly and severally,
represent and warrant to, and agree with, the Initial Purchasers as set forth below in this Section 1:


 


(a)          The
Disclosure Package and the Preliminary Offering Memorandum, each as of 2:45 p.m., Eastern Daylight Time, on August 26, 2015 (the
“Time of Sale”) does not; and the Final Offering Memorandum as of its date and as of the Closing Date will not; include
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements
in or omissions from the Disclosure Package or the Final Offering Memorandum based upon and in conformity with written information
furnished by the Initial Purchasers through the Representatives specifically for use therein, it being understood and agreed that
the only such information furnished by the Initial Purchasers through the Representatives consists of the information described
as such in the last sentence of Section 9(b) hereof.


 




    	 	2	 



     


    

  


(b)          Neither
the Company nor the Adviser (including their agents and representatives, other than the Initial Purchasers in their capacity as
such) have prepared, made, used, authorized, approved, referred to or distributed, nor will prepare, make, use, authorize, approve,
refer to or distribute, any written communication that constitutes an offer to sell or solicitation of an offer to buy the Securities
(each such communication by the Company or its agents and representatives, including in items (iii) and (iv) below, an “Issuer
Written Communication”) other than (i) the Disclosure Package, (ii) the Final Offering Memorandum, (iii) any electronic road
show or other written communications, and (iv) the documents listed on Schedule IV hereto, in each case used in accordance
with Sections 1(r) and 5(b). Each such Issuer Written Communication, when taken together with the Disclosure Package, did not,
as of its date and as of the Time of Sale, and at the Closing Date will not, contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading.


 


(c)          The
capitalization of the Company as of the Closing Date is as set forth under the heading “Capitalization” in the Disclosure
Package and the Final Offering Memorandum. All of the issued and outstanding equity interests of the Company have been duly authorized
and validly issued, are fully paid and nonassessable, have been issued in compliance with federal and state securities laws and
were not issued in violation of any preemptive, right of first refusal, or similar right. Attached as Schedule II is
a true and complete list of each entity in which the Company has a direct or indirect majority equity or voting interest that is
consolidated with the Company for financial reporting purposes under generally accepted accounting principles in the United States
(each, a “Subsidiary” and, together, the “Subsidiaries”) and their jurisdictions of organization. All of
the issued and outstanding equity interests of each Subsidiary have been duly and validly authorized and issued, are fully paid
and nonassessable, have been issued in compliance with federal and state securities laws, were not issued in violation of any preemptive,
right of first refusal, or similar right and, except as set forth in the Final Offering Memorandum, are owned, directly or indirectly,
by the Company free and clear of all liens. Except as set forth in the Final Offering Memorandum, there are no outstanding options,
warrants or other rights to acquire or purchase, or instruments convertible into or exchangeable for, any equity interests of the
Company.


 


(d)          Each
of the Company and each Subsidiary is a corporation, limited liability company or other entity duly organized and validly existing
in good standing under the laws of the jurisdiction of its organization with full corporate, limited liability or requisite other
power and authority to own, lease and operate its properties and assets and to conduct its business as described in the Disclosure
Package and the Final Offering Memorandum, and is duly qualified to conduct business as a foreign corporation and is in good standing
under the laws of each jurisdiction which requires such qualifications, except where the failure to be so qualified and in good
standing would not, individually or in the aggregate, have a material adverse effect on (i) the performance of this Agreement or
the consummation of any of the transactions herein contemplated or (ii) the condition (financial or otherwise), earnings or business
of the Company and its Subsidiaries, considered as one enterprise, whether or not arising from transactions in the ordinary course
of business (a “Material Adverse Effect”).


 


(e)          The
statements in the Disclosure Package and the Final Offering Memorandum under the headings “Description of the Notes,”
“Description of our Other Securities” and “U.S. Federal Income Tax Considerations” fairly summarize the
matters therein described.


 




    	 	3	 



     


    

 


(f)          The
execution and delivery of, and the performance by the Company of its obligations under, this Agreement, the Indenture and each
of the Company Agreements have been duly and validly authorized by the Company, and this Agreement, the Indenture and the Company
Agreements have been duly executed and delivered by the Company and, assuming due execution and delivery hereof by you and thereof
by the counterparties thereto, constitute the valid and legally binding agreements of the Company, enforceable against the Company
in accordance with their terms, except as rights to indemnity and contribution hereunder and thereunder may be limited by federal
or state securities laws or principles of public policy and subject to the qualification that the enforceability of the Company’s
obligations hereunder and thereunder may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium
and other laws relating to or affecting creditors’ rights generally and by general equitable principles, regardless whether
enforcement is considered in a proceeding in equity or at law.


 


(g)          The
Company is a closed-end, non-diversified management investment company and has elected to be treated as a business development
company under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (the “1940 Act”),
has duly filed the Notification of Election with the United States Securities and Exchange Commission (the “Commission”)
and is eligible to make such an election.


 


(h)          The
Securities to be issued and sold by the Company to the Initial Purchasers hereunder have been duly and validly authorized and,
when issued, authenticated and delivered against payment therefor in accordance with this Agreement and the Indenture, will constitute
valid and binding obligations of the Company and will be in the form contemplated by, and entitled to the benefits of, the Indenture;
and the Securities will conform to the description thereof contained in the Indenture, the Disclosure Package and the Final Offering
Memorandum (and any amendment or supplement to any of them). Upon payment for and delivery of the Securities to be sold by the
Company pursuant to this Agreement, the Initial Purchasers will acquire good and valid title to the Securities, in each case free
and clear of all liens, encumbrances, equities, preemptive rights, subscription rights, or any other claim of any third party.


 


(i)          No
consent, approval, authorization, filing with or order of any court or governmental agency or body is required in connection with
the transactions contemplated herein, in the Company Agreements or in the Indenture, other than (i) those under state securities
or blue sky laws of any jurisdiction in connection with the purchase and distribution of the Securities by the Initial Purchasers
in the manner contemplated in this Agreement and in the Disclosure Package and the Final Offering Memorandum, (ii) any necessary
approval of the Corporate Financing Department of the Financial Industry Regulatory Authority, Inc. (“FINRA”), and
(iii) such other approvals as have been obtained, it being understood and agreed that for purposes of this representation and warranty,
the transactions contemplated under the Advisory Agreement do not include any prospective investment transactions generally authorized
therein.


 


(j)          Subsequent
to the respective dates as of which information is given in the Disclosure Package and the Final Offering Memorandum (exclusive
of any amendments or supplements thereto subsequent to the date of this Agreement): (i) there has been no Material Adverse Effect
and (ii) neither the Company nor its Subsidiaries (considered as one enterprise) has incurred any material liability or obligation,
indirect, direct or contingent, not in the ordinary course of business nor entered into any material transaction or agreement not
in the ordinary course of business .


 




    	 	4	 



     


    

 


(k)          Neither
the issuance and sale of the Securities, the execution, delivery or performance of this Agreement, the Indenture or any of the
Company Agreements by the Company, nor the consummation by the Company of the transactions herein or therein contemplated (i) conflicts
or will conflict with or constitutes or will constitute a breach of the charter, bylaws or other organizational documents of the
Company or any Subsidiary, (ii) conflicts or will conflict with or constitutes or will constitute a breach of or a default
under, any material agreement, indenture, lease or other instrument to which the Company is a party or by which it or any of its
properties may be bound, except for such conflicts that would not result in a Material Adverse Effect or (iii) violates or
will violate any material statute, law, regulation or filing or judgment, injunction, order or decree applicable to the Company
or any of its properties or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets
of the Company pursuant to the terms of any agreement or instrument to which it is a party or by which it may be bound or to which
any of the property or assets of the Company is subject, except for such violations that would not result in a Material Adverse
Effect.


 


(l)          There
are no contracts, agreements or understandings between the Company and any person granting such person the right to require the
Company to include any securities of the Company owned or to be owned by such person in the securities offered pursuant to the
Disclosure Package and the Final Offering Memorandum.


 


(m)          The
financial statements, together with related schedules and notes, included or incorporated by reference in the Disclosure Package
and the Final Offering Memorandum, present fairly in all material respects the financial condition, results of operations and cash
flows of the Company as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements
of the 1933 Act and the 1940 Act and have been prepared in conformity with generally accepted accounting principles applied on
a consistent basis throughout the periods involved (except as otherwise noted therein); and the other financial and statistical
information and data included in the Disclosure Package and the Final Offering Memorandum are accurately derived from such financial
statements and the books and records of the Company.


 


(n)          No
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or its property is pending or, to the best knowledge of the Company, threatened that would reasonably be expected to have a Material
Adverse Effect.


 


(o)          The
Company owns or leases all such properties as are necessary to the conduct of its operations as presently conducted.


 


(p)          Neither
the Company nor any Subsidiary is (i) in violation of its charter, bylaws or other organizational document, (ii) in breach or default
in the performance of the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other
agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its property is subject, except
for such breaches or defaults that would not result in a Material Adverse Effect or (iii) in violation of any law, ordinance, administrative
or governmental rule or regulation applicable to any of their or of any decree of the Commission, FINRA, any state securities commission,
any national securities exchange, any arbitrator, any court or any other governmental, regulatory, self-regulatory or administrative
agency or any official having jurisdiction over the Company or its Subsidiaries, except for such violations that would not result
in a Material Adverse Effect.


 


(q)          KPMG
LLP is the independent registered public accounting firm with respect to the Company within the meaning of the 1933 Act. KPMG LLP
has been selected and ratified by the board of directors and stockholders of the Company in compliance with Section 32 of
the 1940 Act. During the periods covered by their respective report in the Disclosure Package and Final Offering Memorandum, each
of KPMG LLP and Grant Thornton LLP was the independent registered public accounting firm with respect to the Company within the
meaning of the 1933 Act.


 




    	 	5	 



     


    

  


(r)          The
Company has not distributed and, prior to the later to occur of (i) the Closing Date and (ii) completion of the distribution of
the Securities, will not distribute any offering material in connection with the offering and sale of the Securities other than
the Disclosure Package, the documents listed on Schedule IV hereto, and any electronic road show in compliance with the
next sentence, and the Final Offering Memorandum. Before making, preparing, using, authorizing, approving or referring to any Issuer
Written Communication, the Company will furnish to the Representatives and counsel for the Initial Purchasers a copy of such Issuer
Written Communication for review and will not make, prepare, use, authorize or refer to such written communication to which the
Representatives reasonably object.


 


(s)          
There are no transfer taxes or other similar fees or charges under federal law or the laws of any state, or any political subdivision
thereof, required to be paid in connection with the execution and delivery of this Agreement or the issuance by the Company or
sale by the Company of the Securities.


 


(t)          Each
of the Company and its Subsidiaries has filed all foreign, federal, state and local tax returns that are required to be filed or
has requested extensions thereof (except in any case in which the failure so to file would not have a Material Adverse Effect)
and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, to the extent that
any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good
faith or as would not have a Material Adverse Effect.


 


(u)          The
Company’s directors and officers/errors and omissions insurance policy and its fidelity bond required by Rule 17g-1 of the
1940 Act are in full force and effect; the Company is in compliance with the terms of such policy and fidelity bond in all material
respects; and there are no claims by the Company under any such policy or fidelity bond; the Company has not been refused any insurance
coverage sought or applied for; and the Company has no reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
its business at a cost that would not have a Material Adverse Effect.


 


(v)         Each
of the Company and its Subsidiaries has such licenses, permits and authorizations of governmental or regulatory authorities (“permits”)
as are necessary to own its property and assets and to conduct its business in the manner described in the Disclosure Package and
the Final Offering Memorandum, except where the failure to obtain such licenses, permits or authorizations would not have a Material
Adverse Effect; the Company and its Subsidiaries have fulfilled and performed all their respective material obligations with respect
to such permits and no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination
thereof or results in any other material impairment of the rights of the Company under any such permit.


 


(w)          The
Securities are eligible for resale pursuant to Rule 144A and there are no securities of the Issuers that are listed on a national
securities exchange registered under Section 6 of the Securities Exchange Act of 1934, as amended, and the rules and regulations
thereunder (the “Exchange Act”) or that are quoted in a United States automated interdealer quotation system of the
same class within the meaning of Rule 144A as the Securities.


 




    	 	6	 



     


    

  


(x)          The
Company maintains and will maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i)
transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles, to calculate
net asset value, to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.


 


(y)          The
Company has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Securities, and the Company is not aware of any such action taken or to be taken by any
affiliates of the Company.


 


(z)          The
Company has established and shall maintain disclosure controls and procedures (as defined in Rule 13a-15 and 15d-15 under the Exchange
Act), which: (i) are designed to ensure that material information relating to the Company is made known to the Company’s
principal executive officer and its principal financial officer by others within the Company, particularly during the periods in
which the periodic reports required under the Exchange Act are being prepared; and (ii) are effective in all material respects
to perform the functions for which they were established.


 


(aa)         The
terms of the Advisory Agreement, including compensation terms, comply in all material respects with the provisions of Sections
15(a) and 15(c) of the 1940 Act (as applicable to business development companies) and Section 205 of the Investment Advisers
Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”).


 


(bb)         The
approvals by the board of directors of the Company of the Advisory Agreement have been made in accordance with the requirements
of Section 15(c) of the 1940 Act applicable to companies that have elected to be regulated as business development companies
under the 1940 Act.


 


(cc)         The
Company is not and, after giving effect to the offering and sale of the Securities, will not be required to register as an “investment
company” or an entity “controlled” by an “investment company,” as such terms are used under the 1940
Act.


 


(dd)         Except
as disclosed in the Disclosure Package and Final Offering Memorandum, (i) no person is serving or acting as an officer, director
or investment adviser of the Company, except in accordance with the provisions of the 1940 Act and the applicable published rules
and regulations thereunder and (ii) to the knowledge of the Company and based on information available to the Company regarding
the initial purchasers, no director of the Company is an “affiliated person” (as defined in the 1940 Act) of any of
the Initial Purchasers; for purposes of this Section 1(dd), the Company shall be entitled to reasonably rely on representations
from such officers and directors.


 


(ee)         There
are no business relationships or related-party transactions involving the Company, any Subsidiary or any other person required
to be described in the Disclosure Package and Final Offering Memorandum which have not been described as required, it being understood
and agreed that the Company and the Adviser make no representation or warranty with respect to any such relationships involving
the Initial Purchasers and any third party that have not been disclosed to the Company.


 




    	 	7	 



     


    

  


(ff)         The
operations of the Company are in material compliance with the provisions of the 1940 Act applicable to business development companies
and the rules and regulations of the Commission thereunder; provided that the Company does not represent or warrant as to
the compliance of Section 9(a) with Section 17(i) of the 1940 Act.


 


(gg)         The
Company has made an election under Section 851(b) of the Internal Revenue Code of 1986, as amended, and the rules and regulations
thereunder (the “Code”), or any successor provisions thereto, to be treated as a regulated investment company (“RIC”)
for federal income tax purposes.


 


(hh)         The
conduct by the Company or any Subsidiary of their respective business (as described in the Disclosure Package and the Final Offering
Memorandum) does not require it to be the owner, possessor or licensee of any patents, patent licenses, trademarks, service marks
or trade names which it does not own, possess or license, except to the extent that a lack of such ownership, possession or license
could not reasonably be expected to have a Material Adverse Effect.


 


(ii)         To
the Company’s knowledge, neither the Company, any Subsidiary nor any employee or agent of the Company or any Subsidiary has
made any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of any law, rule or regulation,
which payment, receipt or retention of funds is of a character required to be disclosed in the Disclosure Package and the Final
Offering Memorandum.


 


(jj)         Neither
the Company nor any Subsidiary (i) has any material lending or other relationship with any bank or lending affiliate of the Initial
Purchasers, except as disclosed in the Disclosure Package and the Final Offering Memorandum and (ii) intends to use any of the
proceeds from the sale of the Securities hereunder, except as disclosed in the Disclosure Package and the Final Offering Memorandum.


 


(kk)         The
Company, and to its knowledge, its directors and officers (in their capacities as such) are in compliance in all material respects
with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated in connection
therewith (the “Sarbanes-Oxley Act”), including Sections 302 and 906 related to certifications.


 


(ll)         The
operations of the Company and the Subsidiaries are and have been conducted at all times in compliance in all material respects
with any applicable financial recordkeeping and reporting requirements of The Bank Secrecy Act of 1970, as amended (including amendments
pursuant to the International Money Laundering Abatement and Anti-Terrorist Financing Act of 2001), the money laundering statutes
of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued,
administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit
or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.


 




    	 	8	 



     


    

 


(mm)         Neither
the Company, any Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company
or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury
Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any other person or entity, for the purpose of financing the activities of any person
currently subject to any U.S. sanctions administered by OFAC.


 


(nn)         Neither
the Company, any Subsidiary nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company
or any Subsidiary is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons
of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), including,
without limitation, making use of the mails or any means or instrumentality of interstate commerce in furtherance of an offer,
payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization
of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political
party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company, any Subsidiary,
and, to the knowledge of the Company, their respective affiliates have conducted their businesses in compliance with the FCPA and
have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.


 


(oo)         Neither
the Company nor any of its affiliates, as such term is defined in Rule 501(b) under the 1933 Act (each, an “Affiliate”),
has, directly or indirectly, solicited any offer to buy, sold or offered to sell or otherwise negotiated in respect of, or will
solicit any offer to buy, sell or offer to sell or otherwise negotiate in respect of, in the United States or to any United States
citizen or resident, any security which is or would be integrated with the sale of the Securities in a manner that would require
the Securities to be registered under the 1933 Act.


 


(pp)         As
of the date hereof, the Company does not have, and at the Closing Date, the Company will not have, any employees.  To
the knowledge of the Company, no labor dispute with the employees of the Adviser exists or is imminent.


 


(qq)         Except
as contemplated by this Agreement, neither the Company, nor any of its Affiliates or any person acting on its or any of their behalf
(other than the Initial Purchasers, as to whom the Company makes no representation) has offered or sold the Securities by means
of any form of general solicitation or general advertising within the meaning of Rule 502(c) under the 1933 Act.


 


(rr)         The
Company has good and valid title to each investment described in the Disclosure Package and the Final Offering Memorandum under
the caption “Portfolio Companies” with corporations or other entities (each a “Portfolio Company”), free
and clear of any liens (except liens disclosed in the Disclosure Package and Final Offering Memorandum); all of the applicable
investment documents and agreements governing such loans (the “Investment Documents and Agreements”) are in full force
and effect; and the Company has no notice of any material claim of any sort that has been asserted by anyone adverse to the right
of the Company under the Investment Documents and Agreements, or affecting or questioning the rights of the Company under any of
the Investment Documents and Agreements; except as disclosed in the Disclosure Package and the Final Offering Memorandum, each
Portfolio Company is current with all of its obligations under the applicable Investment Documents and Agreements and no event
of default (or a default which with the giving of notice or the passage of time would become an event of default) has occurred
or is continuing under such Investment Documents and Agreements.


 




    	 	9	 



     


    

  


(ss)         Subject
to compliance by the Initial Purchasers with the procedures set forth in Section 3 hereof, it is not necessary in connection
with the offer, sale and delivery of the Securities to the Initial Purchasers and to each Subsequent Purchaser in the manner contemplated
by this Agreement, the Disclosure Package and the Final Offering Memorandum to register the Securities under the 1933 Act or to
qualify the Indenture under the Trust Indenture Act of 1939, as amended.


 


Any certificate signed
by any officer of the Company and delivered to the Initial Purchasers or counsel for the Initial Purchasers in connection with
the offering of the Securities shall be deemed a representation and warranty by the Company as to matters covered therein to the
Initial Purchasers.


 


2.           Representations
and Warranties of the Adviser. The Adviser represents and warrants to the Initial Purchasers
as follows: 


 


(a)          The
Adviser is a limited liability company duly formed and validly existing in good standing under the laws of the State of Delaware,
with full limited liability company power and authority to own, lease and operate its properties and assets and to conduct its
business as described in the Disclosure Package and the Final Offering Memorandum, and is duly qualified to do business as a foreign
limited liability company and is in good standing under the laws of each jurisdiction which requires such qualification, except
where the failure to be so qualified and in good standing would not, individually or in the aggregate, have a material adverse
effect on (i) the performance of this Agreement or the consummation of any of the transactions herein contemplated or (ii) the
condition (financial or otherwise), earnings, or business or properties of the Adviser, whether or not arising from transactions
in the ordinary course of business (clauses (i) and (ii) together or individually with respect to the Adviser, an “Adviser
Material Adverse Effect”).


 


(b)          The
Adviser is duly registered with the Commission as an investment adviser under the Advisers Act and is not prohibited by the Advisers
Act or the 1940 Act from acting under the Advisory Agreement as investment adviser to the Company as contemplated by the Disclosure
Package and the Final Offering Memorandum. There does not exist any proceeding or, to the Adviser’s knowledge, any facts
or circumstances the existence of which could lead to any proceeding which might adversely affect the registration of the Adviser
with the Commission.


 


(c)          The
Adviser has full limited liability company power and authority to enter into this Agreement and the Advisory Agreement; the execution
and delivery of this Agreement and the Advisory Agreement to the Adviser, and the performance by the Adviser of its obligations
under this Agreement and the Advisory Agreement, have been duly and validly authorized by the Adviser; and this Agreement and the
Advisory Agreement to the Adviser have been duly executed and delivered by the Adviser and, assuming due execution and delivery
hereof by you, constitute the valid and legally binding agreements of the Adviser, enforceable against the Adviser in accordance
with their terms, except as rights to indemnity and contribution hereunder may be limited by federal or state securities laws or
principles of public policy and subject to the qualification that the enforceability of the Adviser’s obligations hereunder
and thereunder may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium and other laws relating
to or affecting creditors’ rights generally and by general equitable principles, regardless whether enforcement is considered
in a proceeding in equity or at law.


 




    	 	10	 



     


    

 


(d)          The
Adviser has the financial resources and appropriately skilled personnel available to it necessary for the performance of its services
and obligations as described in the Disclosure Package and the Final Offering Memorandum and as contemplated under this Agreement
and the Advisory Agreement.


 


(e)          The
description of the Adviser and its business, and the statements attributable to the Adviser in the Disclosure Package and the Final
Offering Memorandum complied and comply in all material respects with the provisions of the Advisers Act and the 1940 Act and did
not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. The Adviser is not aware that any
executive, key employee or significant group of employees of the Adviser plans to terminate employment with the Company or the
Adviser.


 


(f)          No
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Adviser
or its property is pending or, to the best knowledge of the Adviser, threatened that would reasonably be expected to have an Adviser
Material Adverse Effect.


 


(g)          The
Adviser has such licenses, permits and authorizations of governmental or regulatory authorities (“permits”) as are
necessary to own its property and to conduct its business in the manner described in the Disclosure Package and the Final Offering
Memorandum, except where the failure to obtain such licenses, permits or authorizations would not have an Adviser Material Adverse
Effect. The Adviser has fulfilled and performed all its material obligations with respect to such permits and no event has occurred
which allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other material
impairment of the rights of the Adviser under any such permit.


 


(h)          Neither
the execution, delivery or performance of this Agreement by the Adviser or of the Advisory Agreement nor the consummation by the
Adviser of the transactions herein contemplated or by the Adviser of the transactions therein contemplated (i) conflicts or will
conflict with or constitutes or will constitute a breach of the certificate of formation or limited liability company operating
agreement of the Adviser, (ii) conflicts or will conflict with or constitutes or will constitute a breach of or a default
under, any material agreement, indenture, lease or other instrument to which the Adviser is a party or by which it or any of its
properties may be bound, except for such conflicts that would not result in an Adviser Material Adverse Effect or (iii) violates
or will violate any material statute, law, regulation or filing or judgment, injunction, order or decree applicable to the Adviser
or any of its properties or, other than pursuant to the terms of Section 5(h) hereof, will result in the creation or imposition
of any material lien, charge or encumbrance upon any property or assets of the Adviser pursuant to the terms of any agreement or
instrument to which the Adviser is a party or by which the Adviser may be bound or to which any of the property or assets of the
Adviser is subject, except to the extent for such violations, liens, charges or encumbrances that would not result in an Adviser
Material Adverse Effect, it being understood and agreed that for purposes of this representation and warranty, the transactions
contemplated under the Advisory Agreement do not include any prospective investment transactions generally authorized therein.


 


(i)          The
Adviser has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Securities, and the Adviser is not aware of any such action taken or to be taken by any
affiliates of the Adviser.


 




    	 	11	 



     


    

  


(j)          The
Adviser is not aware that (i) any of the Adviser’s executives, key employees or significant group of employees plans to terminate
employment with the Adviser or (ii) any such executive or key employee is subject to any noncompete, nondisclosure, confidentiality,
employment, consulting or similar agreement that would be violated by the present or proposed business activities of the Company
or the Adviser except where such termination or violation would not constitute an Adviser Material Adverse Effect.


 


Any certificate signed
by any officer of the Adviser and delivered to the Initial Purchasers or counsel for the Initial Purchasers in connection with
the offering of the Securities shall be deemed a representation and warranty by the Adviser, as to matters covered therein, to
the Initial Purchasers.


 


3.          Purchase
and Sale. Subject to the terms and conditions and in reliance upon the representations and
warranties herein set forth, the Company agrees to sell to the Initial Purchasers and the Initial Purchasers agree, severally and
not jointly, to purchase from the Company the aggregate principal amount of Securities set forth opposite its name on Schedule
I attached hereto. The purchase price for the Securities shall be 98.42% of their principal amount.


 


4.          Delivery
and Payment. Delivery of and payment for the Securities shall be made at 10:00 AM, New York
City time, on August 31, 2015, or at such time on such later date not more than three Business Days (as defined below) after the
foregoing date as the Representatives shall designate (such date and time of delivery and payment for the Securities being herein
called the “Closing Date”). Delivery of the Securities shall be made to the Initial Purchasers against payment by the
Initial Purchasers of the purchase price thereof to or upon the order of the Company by wire transfer payable in same-day funds
to an account specified by the Company. Delivery of the Securities shall be made through the facilities of The Depository Trust
Company (“DTC”) unless the Representatives shall otherwise instruct the Company in writing. “Business Day”
shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies
are authorized or obligated by law to close in New York City.


 


5.           Agreements
of the Company and the Adviser. The Company and the Adviser, jointly and severally, agree
with the Initial Purchasers as follows: 


 


(a)          To
furnish the Initial Purchasers and those persons identified by the Initial Purchasers, without charge, as many copies of the Preliminary
Offering Memorandum, the Pricing Supplement, any Issuer Written Communication and the Final Offering Memorandum, and any amendments
or supplements thereto, as the Initial Purchasers may reasonably request. The Issuers consent to the use of the Preliminary Offering
Memorandum, the Pricing Supplement and the Final Offering Memorandum, and any amendments or supplements thereto, by the Initial
Purchasers in connection with resales to Subsequent Purchasers.


 


(b)          As
promptly as practicable following the execution and delivery of this Agreement and in any event not later than the second business
day following the date hereof, to prepare and deliver to the Initial Purchasers the Final Offering Memorandum, which shall consist
of the Preliminary Offering Memorandum as modified only by the information contained in the Pricing Supplement; not to amend or
supplement the Preliminary Offering Memorandum or the Pricing Supplement; not to amend or supplement the Final Offering Memorandum
prior to the Closing Date unless the Initial Purchasers shall previously have been advised of such proposed amendment or supplement
at least two business days prior to the proposed use, and shall not have objected to such amendment or supplement.


 




    	 	12	 



     


    

  


(c)          The
Company will immediately notify the Initial Purchasers, and confirm such notice in writing of (x) any filing made by the Company
of information relating to the offering of the Securities with any securities exchange or any other regulatory body in the United
States or any other jurisdiction, and (y) prior to the earlier of the completion of the placement of the Securities by the Initial
Purchasers or nine months following the Closing Date, any Material Adverse Effect or Adviser Material Adverse Effect which (i)
makes any statement in the Disclosure Package or any Offering Memorandum in light of the circumstances under which they were made,
false or misleading or (ii) is not disclosed in the Disclosure Package or the Final Offering Memorandum. In such event and during
such time any event shall occur as a result of which it is necessary, in the opinion of any of the Company, its counsel, the Representatives
or counsel for the Initial Purchasers, to amend or supplement the Disclosure Package or any Offering Memorandum in order that the
same not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein not misleading in the light of the circumstances then existing, the Company, subject to Section 5(d), will forthwith
amend or supplement the Disclosure Package or such Offering Memorandum, as the case may be, by preparing and furnishing to the
Initial Purchasers an amendment or amendments or supplement or supplements thereto (in form and substance satisfactory in the opinion
of counsel for the Initial Purchasers) so that, as so amended or supplemented, the Disclosure Package or such Offering Memorandum,
as the case may be, does not include an untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing at the time it is delivered to a Subsequent Purchaser,
not misleading.


 


(d)          Prior
to the earlier of the time of completion of the placement of the Securities by the Initial Purchasers to Subsequent Purchasers
or nine months following the Closing Date, the Company will give the Initial Purchasers notice of its intention to prepare any
supplement or amendment to the Offering Memorandum, will furnish the Initial Purchasers with copies of any such amendment or supplement
a reasonable amount of time as practicable prior to such proposed use, and will not use any such amendment or supplement to which
the Representatives or counsel for the Initial Purchasers shall reasonably object. Neither the consent of the Initial Purchasers,
nor the Representatives’ delivery of any such amendment or supplement, shall constitute a waiver of any of the conditions
set forth in Section 6 hereof. The Company will prepare a Pricing Term Sheet, in the form attached hereto as Exhibit A
(the “Pricing Term Sheet”) and shall deliver it to the Initial Purchasers prior to the Time of Sale.


 


(e)          Prior
to the earlier of the time of completion of the placement of the Securities by the Initial Purchasers to Subsequent Purchasers
or nine months following the Closing Date, if any event occurs as a result of which, in the reasonable judgment of the Company,
the Final Offering Memorandum as then supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, the
Company promptly will: (i) notify the Initial Purchasers of any such event; (ii) prepare an amendment or supplement which will
correct such statement or omission or effect such compliance; and (iii) supply any supplemented Offering Memorandum to you in such
quantities as you may reasonably request.


 


(f)          Prior
to the earlier of the time of completion of the placement of the Securities by the Initial Purchasers to Subsequent Purchasers
or nine months following the Closing Date, if there occurs an event or development as a result of which the Disclosure Package
would include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances then prevailing, not misleading, the Company will notify promptly the Initial Purchasers
so that any use of the Disclosure Package may cease until it is amended or supplemented.


 




    	 	13	 



     


    

  


(g)          The
Company will cooperate with the Initial Purchasers and use its reasonable best efforts to permit the Securities to be eligible
for clearance and settlement through the facilities of DTC.


 


(h)          The
Company will arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions as the
Initial Purchasers may designate and will maintain such qualifications in effect so long as required for the distribution of the
Securities; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is
not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of
the offering or sale of the Securities, in any jurisdiction where it is not now so subject. Until the offering of the Securities
is complete, the Company will file all documents required to be filed with the Commission pursuant to the 1940 Act and Exchange
Act within the time periods required thereby.


 


(i)          The
Company and the Adviser will not, without the prior written consent of the Representatives, offer, sell, contract to sell, pledge,
or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the
disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company
or the Adviser or any Affiliate of the Company or any person in privity with the Company or any Affiliate of the Company, directly
or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect
of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of
Section 16 of the Exchange Act) any senior notes or any securities convertible into, or exercisable, or exchangeable for,
senior notes other than the Securities; or publicly announce an intention to effect any such transaction for a period beginning
on the date hereof and extending through the Closing Date.


 


(j)          The
Company and the Adviser will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably
be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Securities.


 


(k)          The
Company will comply with all applicable securities and other applicable laws, rules and regulations, including, without limitation,
the Sarbanes-Oxley Act, and will use its best efforts to cause the Company’s directors and officers, in their capacities
as such, to comply with such laws, rules and regulations, including, without limitation, the provisions of the Sarbanes-Oxley Act.


 


(l)          The
Company agrees to apply the net proceeds from the sale of the Securities in the manner set forth under the caption “Use of
Proceeds” in the Disclosure Package and the Final Offering Memorandum.


 




    	 	14	 



     


    

 


(m)          The
Company agrees to pay the costs and expenses relating to the following matters: (i) the preparation, printing or reproduction of
the Preliminary Offering Memorandum and the Final Offering Memorandum, any Issuer Written Communication and each amendment or supplement
to any of them; (ii) the printing (or reproduction) and delivery (including postage, air freight charges and charges for counting
and packaging) of such copies of the Preliminary Offering Memorandum, Issuer Written Communication and the Final Offering Memorandum
and all amendments or supplements to any of them, as may, in each case, be reasonably requested for use in connection with the
offering and sale of the Securities; (iii) the preparation, printing, authentication, issuance and delivery of certificates for
the Securities, including any stamp or transfer taxes in connection with the original issuance and sale of the Securities to the
Initial Purchasers; (iv) the printing (or reproduction) and delivery of this Agreement, any blue sky memorandum, dealer agreements
and all other agreements or documents printed (or reproduced) and delivered in connection with the offering of the Securities;
(v) any expenses and fees for the cost of ratings agencies; (vi) any registration or qualification of the Securities for offer
and sale under the securities or blue sky laws of the several states (including filing fees and the reasonable and documented fees
and expenses of counsel for the Initial Purchasers relating to such registration and qualification and the preparation of the blue
sky memorandum); (vii) any filings required to be made with FINRA (including filing fees and the reasonable fees and expenses of
counsel for the Initial Purchasers relating to such filings); (viii) the transportation and other expenses of the Company’s
officers in connection with presentations to prospective purchasers of the Securities; (ix) the fees and expenses of the Company’s
accountants and the fees and expenses of counsel (including local and special counsel) for the Company; (x) the costs and
expenses of causing the Securities to continue to be eligible for clearance through DTC; and (xi) all other costs and expenses
incident to the performance by the Company of its obligations hereunder, but not including the fees, expenses, and costs of Nelson
Mullins Riley & Scarborough LLP, counsel to the Initial Purchasers, except as provided in Sections 5(m)(iv), 5(m)(vi) and 5(m)(vii)
above and in Section 8 of this Agreement.


 


(n)          The
Adviser will direct the investment of the net proceeds of the offering of the Securities in such a manner as to comply with the
investment objectives, policies and restrictions of the Company as described in the Disclosure Package and the Final Offering Memorandum.


 


(o)          The
Company will advise the Initial Purchasers promptly, confirming such advice in writing, of the receipt of any notification with
respect to the modification, rescission, withdrawal or suspension of the qualification of the Securities, or of any exemption from
such qualification or from registration of the Securities, for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceedings for any of such purposes, including notices of any action or investigation by the Commission regarding the Company,
and, if any government agency or authority should issue any such order, to make every reasonable effort to obtain the lifting or
removal of such order as soon as possible.


 


(p)          The
Company shall use its commercially reasonable efforts to maintain its qualification to be treated as a RIC under Subchapter M of
the Code, for each full fiscal year during which it is a business development company under the 1940 Act.


 


(q)          The
Company and the Adviser will use their reasonable best efforts to perform all of the agreements required of them by this Agreement
and discharge all their conditions to closing as set forth in this Agreement.


 


(r)          The
Company shall cause the Securities, prior to the Closing Date, to be assigned the rating set forth in the Pricing Term Sheet attached
hereto as Exhibit A.


 


6.           Conditions
to the Obligation of the Initial Purchasers. The obligation of the Initial Purchasers to
purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company and the
Adviser contained herein as of the date and time that this Agreement is executed and delivered by the parties hereto (the “Execution
Time”), the Time of Sale and the Closing Date, to the accuracy of the statements of the Company or the Adviser made in any
certificates pursuant to the provisions hereof, to the performance by the Company or the Adviser of its obligations hereunder and
to the following additional conditions (except to the extent that any such conditions may have been waived in writing by the Initial
Purchasers on or prior to such respective dates): 


 




    	 	15	 



     


    

  


(a)          The
Company shall have requested and caused Moore & Van Allen PLLC, Venable LLP, and Sutherland Asbill & Brennan LLP, counsel
for the Company, to have furnished to the Initial Purchasers their respective opinions, dated the Closing Date and addressed to
the Initial Purchasers, each in the form and substance as set forth in Exhibit B hereto and to such further effect
as the Representatives may reasonably request:


 


(b)          The
Initial Purchasers shall have received on the Closing Date the favorable opinion of Nelson Mullins Riley & Scarborough LLP,
counsel for the Initial Purchasers, dated the Closing Date and addressed to the Initial Purchasers.


 


(c)          Each
of the Company and the Adviser shall have furnished to the Initial Purchasers certificates, signed by the Chief Executive Officer
and the principal financial or accounting officer of the Company and by the manager of the Adviser, each dated the Closing Date,
to the effect that the signers of such certificates have carefully examined the Disclosure Package, the Final Offering Memorandum,
any supplements or amendments to the Final Offering Memorandum and this Agreement and that:


 


(i)          The
representations and warranties of the Company and the Adviser in this Agreement are true and correct as of the date hereof, as
of the Time of Sale and on and as of the Closing Date with the same effect as if made on the Closing Date and the Company and the
Adviser have complied with all the agreements and satisfied all the conditions on its part that are respectively required to be
performed or satisfied by them at or prior to the Closing Date; and


 


(ii)         Since
the date of the most recent financial statements included or incorporated in the Disclosure Package and the Final Offering Memorandum
(with respect to the certificate of the Company) and since the dates of the Disclosure Package and the Final Offering Memorandum
(with respect to the certificate of the Adviser), there has been no Material Adverse Effect or Adviser Material Adverse Effect.


 


(d)          The
Company shall have requested and caused KPMG LLP and Grant Thornton LLP to each have furnished to the Initial Purchasers, at the
Execution Time and at the Closing Date, letters, dated respectively as of the Execution Time and as of the Closing Date, in form
and substance heretofore approved by the Representatives.


 


(e)          Subsequent
to the Execution Time or, if earlier, the dates as of which information is given in the Disclosure Package (exclusive of any supplement
thereto) and the Final Offering Memorandum (exclusive of any supplement thereto), there shall not have been (i) any material change
specified in the letter or letters referred to in paragraph (d) of this Section 6 delivered on the Closing Date from the letter
delivered at the Execution Time or (ii) any change in the condition (financial or otherwise), earnings, business or properties
of the Company and its Subsidiaries, considered as one enterprise, and the Adviser, whether or not arising from transactions in
the ordinary course of business except as set forth in or contemplated in the Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto), the effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole
judgment of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering
or delivery of the Securities as contemplated by the Disclosure Package and the Final Offering Memorandum (exclusive of any supplement
thereto).




    	 	16	 



     


    

 


(f)          The
Issuers and the Trustee shall have executed and delivered the Indenture in form and substance satisfactory to the Initial Purchasers
and the Initial Purchasers shall have received copies thereof.


 


(g)          Prior
to the Closing Date, the Company and the Adviser shall have furnished to the Initial Purchasers such further information, certificates
and documents as the Initial Purchasers may reasonably request.


 


(h)          Subsequent
to the Execution Time, there shall not have been any decrease in the rating of any of the Company’s debt securities by any
“nationally recognized statistical rating organization” (as defined in Section 3(a)(62) of the Exchange Act) or
any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does
not indicate the direction of the possible change.


 


(i)          All
agreements set forth in the DTC Agreement relating to the approval of the Notes by DTC for “book-entry” transfer shall
have been complied with.


 


If any of the conditions
specified in this Section 6 shall not have been fulfilled when and as provided for in this Agreement, or if any of the opinions
and certificates mentioned above or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance to the
Representatives and counsel for the Initial Purchasers, this Agreement and all obligations of the Initial Purchasers hereunder
may be canceled at, or at any time prior to, the Closing Date by the Representatives (unless any such conditions have been waived
in writing by the Representatives on or prior to such respective dates). Notice of such cancellation shall be given to the Company
in writing or by telephone or facsimile confirmed in writing.


 


The documents required
to be delivered by this Section 6 shall be delivered at the office of Nelson Mullins Riley & Scarborough LLP, counsel
for the Initial Purchasers, at 101 Constitution Avenue, NW, Suite 900, Washington, DC 20001, Attention: Jonathan H. Talcott,
on the Closing Date.


 


7.           Subsequent
Offers and Resales of the Securities.


 


(a)          The
Initial Purchasers and the Company, as applicable, hereby establishes, represents and warrants and agrees to observe the following
procedures in connection with the offer and sale of the Securities:


 


(i)          Offers
and sales of the Securities shall only be made to persons whom the offeror or seller reasonably believes to be qualified institutional
buyers, as defined in Rule 144A under the 1933 Act (“Qualified Institutional Buyers”).


 


(ii)         Other
than those items listed on Schedule III hereto, no general solicitation or general advertising (within the meaning of Rule
502(c) under the 1933 Act or any manner involving a public offering within the meaning of Section 4(a)(2) of the 1933 Act)
has been or will be used in the United States in connection with the offering or sale of the Securities.


 




    	 	17	 



     


    

 


(iii)        Prior
to or contemporaneously with the purchase of any Securities, the applicable Initial Purchasers will inform persons acquiring Securities
from the Initial Purchasers that the Securities (A) have not been and will not be registered under the 1933 Act, (B) are being
sold to them without registration under the 1933 Act in reliance on Rule 144A, and (C) may not be offered, sold or otherwise transferred
except (1) to the Company or any of its subsidiaries, (2) as long as the Securities are eligible for resale pursuant to Rule 144A,
to a person whom the seller reasonably believes is a Qualified Institutional Buyer that is purchasing such Securities for its own
account or for the account of a Qualified Institutional Buyer to whom notice is given that the offer, sale or transfer is being
made in reliance on Rule 144A or (3) pursuant to any other available exemption from the registration requirements of the 1933 Act.


 


(iv)        The
notice to investors and the other provisions set forth in the Offering Memorandum under the heading “Notice to Investors,”
including the legend required thereby, shall apply to the Securities, except as otherwise agreed by the Company and the Initial
Purchasers. Following the sale of the Securities by the Initial Purchasers to Subsequent Purchasers pursuant to the terms hereof,
the Initial Purchasers shall not be liable or responsible to the Company for any losses, damages or liabilities suffered or incurred
by the Company, including any losses, damages or liabilities under the 1933 Act, arising from or relating to any resale, transfer
or exchange of any Note by any Subsequent Purchaser.


 


(b)          Covenants
of the Company. The Company covenants with the Initial Purchasers as follows:


 


(i)          The
Company agrees that it will not, and will cause its Affiliates not to, directly or indirectly, solicit any offer to buy, sell or
make any offer or sale of, or otherwise negotiate in respect of, securities of the Company of any class if, as a result of the
doctrine of “integration” referred to in Rule 502 under the 1933 Act, such offer or sale would render invalid (for
the purpose of (A) the offer and, if applicable, sale of the Securities by the Company to the Initial Purchasers, (B) the reoffer
and, if applicable, resale of the Securities by the Initial Purchasers to Subsequent Purchasers or (C) the reoffer and, if applicable,
resale of the Securities by such Subsequent Purchasers to others) the exemption from the registration requirements of the 1933
Act provided by Section 4(a)(2) thereof or by Rule 144A thereunder or otherwise.


 


(ii)         The
Company agrees that, in order to render the Securities eligible for resale pursuant to Rule 144A under the 1933 Act, while any
of the Securities remain outstanding and during any period in which the Company is not subject to Section 13 or 15(d) of the
Exchange Act, it will make available, upon request, to any holder or beneficial owner of Securities or prospective purchasers of
Securities the information specified in Rule 144A(d)(4). In addition, to the extent the Company is subject to Section 13
or 15(d) of the Exchange Act, the Company shall timely file all reports under the Exchange Act.


 


(iii)        Until
the expiration of one year after the original issuance of the Securities, the Company will not, and will cause its Affiliates not
to, resell any of the Securities which are “restricted securities” (as such term is defined under Rule 144(a)(3) under
the 1933 Act), whether as beneficial owner or otherwise (except as agent acting as a securities broker on behalf of and for the
account of customers in the ordinary course of business in unsolicited brokers’ transactions).


 




    	 	18	 



     


    

  


(c)          Qualified
Institutional Buyer. The Initial Purchasers each represent and warrant to, and agree with, the Company that it is a Qualified
Institutional Buyer and an “accredited investor” within the meaning of Rule 501(a) under the 1933 Act.


 


8.           Reimbursement
of Initial Purchasers’ Expenses. Other than pursuant to a termination of this Agreement
pursuant to Section 10(b) hereof, if the sale of the Securities provided for herein is not consummated (i) because any condition
to the obligations of the Initial Purchasers set forth in Section 6 hereof is not satisfied, (ii) because of any termination
of this Agreement pursuant to Section 10(a) hereof, or (iii) because of any refusal, inability or failure on the part of the
Company or the Adviser to perform any agreement herein or comply with any provision hereof, the Company will reimburse the Initial
Purchasers on demand for all out-of-pocket expenses (including reasonable and documented fees and disbursements of counsel) that
shall have been incurred by it in connection with the proposed purchase and sale of the Securities. 


 


9.           Indemnification
and Contribution.


 


(a)          The
Company and the Adviser, jointly and severally, agree to indemnify and hold harmless each of the Initial Purchasers, the directors,
officers, employees and agents of the Initial Purchasers and each person who controls the Initial Purchasers within the meaning
of either the 1933 Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or several (including
reasonable and documented costs of investigation), to which they or any of them may become subject under the 1933 Act, the Exchange
Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages
or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement
of a material fact contained in any Preliminary Offering Memorandum, the Disclosure Package, any Issuer Written Communication (including,
but not limited to, any electronic road show or the Final Offering Memorandum (or any amendment or supplement to any of the foregoing)),
or (ii) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading, and subject to the provisions
hereof, agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them
in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however,
that the Company and the Adviser will not be liable in any such case to the extent that any such loss, claim, damage or liability
arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein
in reliance upon and in conformity with written information furnished to the Company and the Adviser by the Initial Purchasers
through the Representatives specifically for inclusion therein, it being understood that the only information furnished by the
Initial Purchasers consists of the information described as such in the last sentence of Section 9(b). This indemnity agreement
will be in addition to any liability which the Company and the Adviser may otherwise have to the indemnified parties.


 


(b)          The
Initial Purchasers agree, severally and not jointly, to indemnify and hold harmless each of the Company and the Adviser, the directors,
employees, as applicable, officers and agents of the Company and the Adviser and each person who controls the Company or the Adviser
within the meaning of either the 1933 Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company and
the Adviser to the Initial Purchasers, but only with reference to written information relating to the Initial Purchasers furnished
to the Company or the Adviser by the Initial Purchasers specifically for inclusion in the documents referred to in the foregoing
indemnity. This indemnity agreement will be in addition to any liability which the Initial Purchasers may otherwise have to the
Company and the Adviser. The Company and the Adviser acknowledge that the statements set forth in the second sentence of the third
paragraph and the first five sentences of the eleventh paragraph of the section titled “Plan of Distribution” in any
Preliminary Offering Memorandum and the Final Offering Memorandum constitute the only information furnished in writing by the Initial
Purchasers through the Representatives for inclusion in any Preliminary Offering Memorandum or the Final Offering Memorandum.


 




    	 	19	 



     


    

  


(c)          Promptly
after receipt by an indemnified party under this Section 9 of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against the indemnifying party under this Section 9, notify the indemnifying
party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve the indemnifying
party from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such
failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event,
relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided
in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice
at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought
(in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained
by the indemnified party or parties except as set forth below) and to control such action; provided, however, that such
counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel
to represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including
local counsel), and the indemnifying party shall bear the reasonable and documented fees, costs and expenses of such separate counsel
if (A) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a
conflict of interest, (B) the actual or potential defendants in, or targets of, any such action include both the indemnified party
and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available
to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, (C)
the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of the institution of such action or (D) the indemnifying party shall authorize the
indemnified party to employ separate counsel at the expense of the indemnifying party.


 




    	 	20	 



     


    

 


(d)          In
the event that the indemnity provided in paragraph (a) or (b) of this Section 9 is unavailable to or insufficient to hold
harmless an indemnified party for any reason, the Company, the Adviser and the Initial Purchasers severally agree to contribute
to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with
investigating or defending same) (collectively “Losses”) to which the Company, the Adviser and the Initial Purchasers
may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the Adviser, on
the one hand (treated jointly for this purpose as one person), and by the Initial Purchasers, on the other, from the offering of
the Securities; provided, however, that in no case shall the Initial Purchasers be responsible for any amount in excess
of the Initial Purchasers’ discount or commission applicable to the Securities purchased by the Initial Purchasers hereunder.
If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company, the Adviser and the
Initial Purchasers severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but
also the relative fault of the Company and the Adviser, on the one hand (treated jointly for this purpose as one person), and of
the Initial Purchasers, on the other, in connection with the statements or omissions which resulted in such Losses as well as any
other relevant equitable considerations. Benefits received by the Company, and the Adviser (treated jointly for this purpose as
one person) shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by it,
and benefits received by the Initial Purchasers shall be deemed to be equal to the total Initial Purchasers’ discounts and
commissions, in each case as set forth on the cover page of the Final Offering Memorandum. Relative fault of the parties shall
be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information provided by the Company and the Adviser, on the one
hand (treated jointly for this purpose as one person), or the Initial Purchasers, on the other, the intent of the parties and their
relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company,
the Adviser and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 9
were determined by pro rata allocation or any other method of allocation which does not take account of the equitable considerations
referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. For purposes of this Section 9, each person who controls the Initial Purchasers within the meaning
of either the 1933 Act or the Exchange Act and each director, officer, employee and agent of the Initial Purchasers shall have
the same rights to contribution as the Initial Purchasers, and each person who controls the Company or the Adviser within the meaning
of either the 1933 Act or the Exchange Act, and each director, officer and agent of the Company and the Adviser shall have the
same rights to contribution as the Company and the Adviser, subject in each case to the applicable terms and conditions of this
paragraph (d).


 


(e)          No
indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened
action, suit or proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party, unless such settlement (i) includes an unconditional release of such indemnified party
from all liability from claimants on claims that are the subject matter of such action, suit or proceeding and (ii) does not include
a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. Subject to
the following sentence, an indemnifying party shall not be liable to an indemnified party under this Section 9 for any settlement
of any claim or action effected without the prior written consent of such indemnifying party, which shall not be unreasonably withheld.
If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and
expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by this
Section 9 effected without its written consent if (A) such settlement is entered into more than 45 days after receipt by such
indemnifying party of the aforesaid request, (B) such indemnifying party shall have received notice of the terms of such settlement
at least 30 days prior to such settlement being entered into and (C) such indemnifying party shall not have reimbursed such indemnified
party in accordance with such request prior to the date of such settlement.




 






    	 	21	 



     


    





 


(f)          Any
losses, claims, damages, liabilities or expenses for which an indemnified party is entitled to indemnification or contribution
under this Section 9 shall be paid by the indemnifying party to the indemnified party as such losses, claims, damages, liabilities
or expenses are incurred. The indemnity and contribution agreements contained in this Section 9 and the representations and
warranties of the Company and the Adviser set forth in this Agreement shall remain operative and in full force and effect, regardless
of (i) any investigation made by or on behalf of the Initial Purchasers or any person controlling the Initial Purchasers, the Company,
the Adviser or their shareholders, trustees, directors, managers, members or officers or any person controlling the Company or
the Adviser (control to be determined within the meaning of the 1933 Act or the Exchange Act), (ii) acceptance of any Securities
and payment therefor hereunder and (iii) any termination or cancellation of this Agreement. A successor to the Initial Purchasers
or to the Company, the Adviser or their shareholders, trustees, directors, managers, members or officers or any person controlling
the Initial Purchasers, the Company or the Adviser shall be entitled to the benefits of the indemnity, contribution and reimbursement
agreements contained in this Section 9.


 


10.          Termination.


 


(a)          This
Agreement shall be subject to termination in the absolute discretion of the Initial Purchasers, without liability on the part of
the Initial Purchasers to the Company or the Adviser, by notice given to the Company, or the Adviser prior to delivery of and payment
for the Securities, if at any time prior to such time (A) there has been, since the Execution Time, or since the respective dates
as of which information is given in the Disclosure Package and the Final Offering Memorandum, any material adverse change in the
condition (financial or otherwise), earnings, business or properties of the Company and its Subsidiaries, considered as a single
enterprise, or the Adviser, whether or not arising in the ordinary course of business, which would, in the sole judgment of the
Representatives, make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated
by the Preliminary Offering Memorandum or the Final Offering Memorandum (exclusive of any supplement thereto), (B) trading
in securities generally on the New York Stock Exchange, Inc. (the “NYSE”) shall have been suspended or limited or minimum
prices shall have been established on the NYSE, (C) a banking moratorium shall have been declared either by federal or New
York State authorities, (D) a material disruption has occurred in securities settlement or securities clearance in the United States
or (E) there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency
or war, or other calamity or crisis the effect of which on financial markets is such as to make it, in the sole judgment of the
Representatives, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Preliminary
Offering Memorandum or the Final Offering Memorandum (exclusive of any supplement thereto).


 


(b)          If
any one or more Initial Purchasers shall fail to purchase and pay for any of the Securities agreed to be purchased by such Initial
Purchaser hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under
this Agreement, the remaining Initial Purchasers shall be obligated severally to take up and pay for (in the respective proportions
which the principal amount of Securities set forth opposite their names in Schedule I hereto bears to the aggregate
principal amount of Securities set forth opposite the names of all the remaining Initial Purchasers) the Securities which the defaulting
Initial Purchaser or Initial Purchasers agreed but failed to purchase; provided, however, that in the event that
the aggregate principal amount of Securities which the defaulting Initial Purchaser or Initial Purchasers agreed but failed to
purchase shall exceed 10% of the aggregate principal amount of Securities set forth in Schedule I hereto, the remaining Initial
Purchasers shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Securities, and
if such nondefaulting Initial Purchasers do not purchase all the Securities, this Agreement will terminate without liability to
any nondefaulting Initial Purchaser or the Company. In the event of a default by any Initial Purchaser as set forth in this Section 10(b),
the Closing Date shall be postponed for such period, not exceeding seven Business Days, as the Representatives shall determine
in order that the required changes in the Final Offering Memorandum or in any other documents or arrangements may be effected.
Nothing contained in this Agreement shall relieve any defaulting Initial Purchaser of its liability, if any, to the Company or
any nondefaulting Initial Purchaser for damages occasioned by its default hereunder.


 




    	 	22	 



     

    

 


11.         Representations
and Indemnities to Survive. The respective agreements, representations, warranties, indemnities
and other statements of each of the Company, and the Adviser or its officers and of the Initial Purchasers set forth in or made
pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Initial
Purchasers or the Company or the Adviser or any of the officers, trustees, directors, employees, agents or controlling persons
referred to in Section 9 hereof, and will survive delivery of and payment for the Securities. The provisions of Sections 8
and 9 hereof shall survive the termination or cancellation of this Agreement. 


 


12.         No
Fiduciary Duty. The Company hereby acknowledges and agrees that (a) the purchase and sale
of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand,
and the Initial Purchasers and any affiliate through which they may be acting, on the other, (b) the Initial Purchasers are acting
as principal and not as an agent or fiduciary of the Company and (c) the Company’s engagement of the Initial Purchasers in
connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity.
Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective
of whether the Initial Purchasers has advised or is currently advising the Company on related or other matters). The Company agrees
that it will not claim that the Initial Purchasers have rendered advisory services of any nature or respect, or owe an agency,
fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. 


 


13.         Integration.
This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company, the Adviser and
the Initial Purchasers, or any of them, with respect to the subject matter hereof. 


 


14.         Notices.
Except as otherwise herein provided, all statements, requests, notices and agreements shall be in writing or by telegram or facsimile
and, if to the Initial Purchasers, shall be sufficient in all respects if delivered or sent to Sandler O’Neill & Partners,
L.P. on behalf of the Initial Purchasers, 1251 Avenue of the Americas, 6th Floor, New York, New York 10020, with a copy
(for informational purposes only) to Jonathan H. Talcott, Nelson Mullins Riley & Scarborough, LLP, 101 Constitution Avenue,
NW, Suite 900, Washington, DC 20001; and if to the Company or Adviser, shall be sufficient in all respects if delivered or sent
to the Company at the offices of the Company at 405 Park Avenue, 14th Floor, New York, New York, Attention: Robert Grunewald,
with a copy to Moore & Van Allen PLLC, 100 North Tryon Street, Suite 4700, Charlotte, North Carolina, Attention: Michael Denny.


 


15.         Successors.
This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers,
trustees, directors, employees, agents and controlling persons referred to in Section 9 hereof, and no other person will have
any right or obligation hereunder. 


 


16.         Applicable
Law; Waiver of Jury Trial. This Agreement will be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed within the State of New York. The parties
hereby waive any right to trial by jury in any action, proceeding or counterclaim arising out of or relating to this Agreement
or the transactions contemplated hereby.


 




    	 	23	 



     

    

 


17.         Counterparts.
This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together
shall constitute one and the same agreement. 


 


18.         Headings.
The section headings used herein are for convenience only and shall not affect the construction hereof. 


 


If the foregoing is
in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this
letter and your acceptance shall represent a binding agreement among the Company, the Adviser and the Initial Purchasers.




 


	 	Very truly yours,
	 	 
	 	BUSINESS DEVELOPMENT CORPORATION OF AMERICA
	 	 	 
	 	By:	/s/ Peter M. Budko
	 	 	Name: Peter M. Budko
	 	 	Title: Chairman & Chief Executive Officer
	 	 	 
	 	BDCA ADVISER, LLC
	 	 	 
	 	By:	/s/ Peter M. Budko
	 	 	Name: Peter M. Budko
	 	 	Title:  Chief Executive Officer


 


[Signature Page to Purchase Agreement]


 




    	 	24	 



     

    

 


Accepted and
agreed to as of the date first above written, on behalf of themselves and the Initial Purchasers named herein:


 


	SANDLER O’NEILL & PARTNERS, L.P.	 
	 	 	 
	By:	/s/ Bob Kleinert	 
	 	Name: Bob Kleinert	 
	 	Title: Managing Principal	 
	 	 	 
	KEEFE, BRUYETTE & WOODS, INC.	 
	 	 	 
	By:	/s/ Allen G. Laufenberg	 
	 	Name: Allen G. Laufenberg	 
	 	Title: Managing Director	 
	 	 	 
	UBS SECURITIES LLC	 
	 	 	 
	By:	/s/ Mehdi Manii	 
	 	Name: Mehdi Manii	 
	 	Title: Director	 
	 	 	 
	By:	/s/ Samuel Reinhart	 
	 	Name: Samuel Reinhart	 
	 	Title: Managing Director	 


 


[Signature Page to Purchase Agreement]


 




    	 	25	 



     

    

 


SCHEDULE I


 


 



 


	Initial Purchasers	 	Aggregate Principal
 Amount of
 Notes to Be Purchased	 
	 	 	 	 
	Sandler O’Neill & Partners, L.P.	 	$	37,000000	 
	 	 	 	 	 
	Keefe, Bruyette & Woods, Inc.	 	$	27,000,000	 
	 	 	 	 	 
	UBS Securities LLC	 	$	27,000,000	 
	 	 	 	 	 
	William Blair & Company, L.L.C.	 	$	6,000,000	 
	 	 	 	 	 
	Ladenburg Thalmann & Co. Inc.	 	$	3,000,000	 
	 	 	 	 	 
	Total	 	$	100,000,000	 



 




    	 	I-1	 



     

    

 


SCHEDULE II 


 


SUBSIDIARIES


 


	Name	 	Domicile
	54th Street Equity Holdings, Inc.	 	Delaware
	BDCA-CB Funding, LLC	 	Delaware
	BDCA Funding I, LLC	 	Delaware
	BDCA 2L Funding I, LLC	 	Delaware
	Kahala Aviation Holdings, LLC	 	Delaware
	Kahala Aviation US, Inc.	 	Delaware
	Kahala Luxco	 	Luxembourg
	Park Ave RE, Inc.	 	Delaware


 




    	 	II-1	 



     

    

 


SCHEDULE III


 


PERMITTED SOLICITATIONS


 


		1.	Pricing Term Sheet



 


		2.	Bloomberg deal announcement dated June 24, 2015



 


		3.	Current Report on Form 8-K dated June 24, 2015



 


		4.	Bloomberg deal announcement dated August 25, 2015



 




    	 	III-1	 



     

    

 


SCHEDULE IV


 


OTHER ISSUER WRITTEN COMMUNICATIONS


 


		1.	The Preliminary Offering Memorandum dated June 3, 2015



 


		2.	The Preliminary Offering Memorandum dated June 19, 2015



 


		3.	The Preliminary Offering Memorandum dated July 8, 2015



 


		4.	Unpledged Collateral Analysis (Schedule of Investments) provided to certain investors beginning
June 5, 2015 in connection with the road show



 


		5.	Schedule of Investments in Diversified Investment Vehicles provided to Bond Street on June 23,
2015



 




    	 	IV-1	 



     

    

 


EXHIBIT A


Pricing Term Sheet


 


[Attached]


 



    	 	A-1	 



     

    

 


Exhibit B


Forms of Company Counsel Opinions


 


[Attached]


 




    	 	B-1